Blueberry Therapeutics   Report issue

For profit Phase 2
Founded: Alderley Edge United Kingdom (2011)

Organization Overview

First Clinical Trial
2020
NCT04188574
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Blueberry Therapeutics